Loading...

KemPharm, Inc.

KMPH•NASDAQ
Healthcare
Biotechnology
$5.81
$-0.02(-0.34%)

KemPharm, Inc. (KMPH) Stock Overview

Explore KemPharm, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.4/100

Key Financials

Market Cap200.5M
P/E Ratio-2.20
EPS (TTM)$-0.91
ROE-3.12%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.71

KMPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of KemPharm, Inc. (KMPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.20 and a market capitalization of 200.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;